Marleen Keyaerts

Phase I Study of ⁶⁸Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma

Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk et al. · Journal of Nuclear Medicine · 2015 · 435 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Synthesis, Preclinical Validation, Dosimetry, and Toxicity of ⁶⁸Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer

Catarina Xavier, Ilse Vaneycken, Matthias D’Huyvetter et al. · Journal of Nuclear Medicine · 2013 · 223 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of the Biodistribution and Tumor Targeting of Two ^99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT

Lea Olive Tchouate Gainkam, Lieven Huang, Vicky Caveliers et al. · Journal of Nuclear Medicine · 2008 · 218 citations · Full text

Medicine, Oncology, Pharmacology +17

Immunogenicity Risk Profile of Nanobodies

Chloé Ackaert, Natalia Smiejkowska, Catarina Xavier et al. · Frontiers in Immunology · 2021 · 218 citations · Full text

Pharmacy, Immunology, Oncology +17

SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression

Lieven Huang, Lea Olive Tchouate Gainkam, Vicky Caveliers et al. · Molecular Imaging and Biology · 2008 · 188 citations

Medicine, Nuclear Medicine, Radiology +16